A citation-based method for searching scientific literature

Navid Neyshaburinezhad, Hengameh Ghasim, Mohammadreza Rouini, Youssef Daali, Yalda H Ardakani. J Pers Med 2021
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Functional SNPs of the breast cancer resistance protein-therapeutic effects and inhibitor development.
Kae Yanase, Satomi Tsukahara, Junko Mitsuhashi, Yoshikazu Sugimoto. Cancer Lett 2006
50
50

Analysis of genotype and haplotype effects of ABCB1 (MDR1) polymorphisms in the risk of medically refractory epilepsy in an Indian population.
Saadi Abdul Vahab, Supratim Sen, Nivedita Ravindran, Sridevi Mony, Anila Mathew, Neetha Vijayan, Geetha Nayak, Nalini Bhaskaranand, Moinak Banerjee, Kapaettu Satyamoorthy. Drug Metab Pharmacokinet 2009
52
50

Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression.
P Kuehl, J Zhang, Y Lin, J Lamba, M Assem, J Schuetz, P B Watkins, A Daly, S A Wrighton, S D Hall,[...]. Nat Genet 2001
50

Association of ABCB1 C3435T polymorphism with phenobarbital resistance in Thai patients with epilepsy.
T Keangpraphun, S Towanabut, Y Chinvarun, P Kijsanayotin. J Clin Pharm Ther 2015
15
50

Major SNP (Q141K) variant of human ABC transporter ABCG2 undergoes lysosomal and proteasomal degradations.
Tomoka Furukawa, Kanako Wakabayashi, Ai Tamura, Hiroshi Nakagawa, Yoshihiro Morishima, Yoichi Osawa, Toshihisa Ishikawa. Pharm Res 2009
100
50

Current strategies to minimize toxicity of oxaliplatin: selection of pharmacogenomic panel tests.
Raffaele Di Francia, Raffaella Stefania Siesto, Daniela Valente, Andrea Del Buono, Sergio Pugliese, Sabrina Cecere, Carla Cavaliere, Guglielmo Nasti, Gaetano Facchini, Massimiliano Berretta. Anticancer Drugs 2013
25
50


Genetic variations and haplotype diversity of the UGT1 gene cluster in the Chinese population.
Jing Yang, Lei Cai, Haiyan Huang, Bingya Liu, Qiang Wu. PLoS One 2012
14
50

Stereoselective conjugation of oxazepam by human UDP-glucuronosyltransferases (UGTs): S-oxazepam is glucuronidated by UGT2B15, while R-oxazepam is glucuronidated by UGT2B7 and UGT1A9.
Michael H Court, Su X Duan, Chantal Guillemette, Kim Journault, Soundararajan Krishnaswamy, Lisa L Von Moltke, David J Greenblatt. Drug Metab Dispos 2002
138
50

The novel UGT1A9 intronic I399 polymorphism appears as a predictor of 7-ethyl-10-hydroxycamptothecin glucuronidation levels in the liver.
Hugo Girard, Lyne Villeneuve, Michael H Court, Louis-Charles Fortier, Patrick Caron, Qin Hao, Lisa L von Moltke, David J Greenblatt, Chantal Guillemette. Drug Metab Dispos 2006
65
50

Genetic polymorphisms in CYP3A4 are associated with withdrawal symptoms and adverse reactions in methadone maintenance patients.
Chia-Hui Chen, Sheng-Chang Wang, Hsiao-Hui Tsou, Ing-Kang Ho, Jia-Ni Tian, Cheng-Jou Yu, Chin-Fu Hsiao, Sun-Yuan Chou, Yen-Feng Lin, Kai-Chi Fang,[...]. Pharmacogenomics 2011
38
50

Ethnicity-related polymorphisms and haplotypes in the human ABCB1 gene.
Chava Kimchi-Sarfaty, Andrew H Marple, Shiri Shinar, Avraham M Kimchi, David Scavo, M Isabella Roma, In-Wha Kim, Adam Jones, Mili Arora, John Gribar,[...]. Pharmacogenomics 2007
71
50

Evidence of significant contribution from CYP3A5 to hepatic drug metabolism.
Weili Huang, Yvonne S Lin, Donavon J McConn, Justina C Calamia, Rheem A Totah, Nina Isoherranen, Mary Glodowski, Kenneth E Thummel. Drug Metab Dispos 2004
132
50

Interethnic differences in the relevance of CYP2C9 genotype and environmental factors for diclofenac metabolism in Hispanics from Cuba and Spain.
A Llerena, M Alvarez, P Dorado, I González, E Peñas-LLedó, B Pérez, J Cobaleda, L R Calzadilla. Pharmacogenomics J 2014
26
50


Genetic polymorphisms and valproic acid plasma concentration in children with epilepsy on valproic acid monotherapy.
Shenghui Mei, Weixing Feng, Leting Zhu, Yazhen Yu, Weili Yang, Baoqin Gao, Xiaojuan Wu, Zhigang Zhao, Fang Fang. Seizure 2017
12
50

Valproic acid pathway: pharmacokinetics and pharmacodynamics.
Yogita Ghodke-Puranik, Caroline F Thorn, Jatinder K Lamba, J Steven Leeder, Wen Song, Angela K Birnbaum, Russ B Altman, Teri E Klein. Pharmacogenet Genomics 2013
168
50

Effects of UGT2B7 Genetic Polymorphisms on Serum Concentrations of Valproic Acid in Chinese Children With Epilepsy Comedicated With Lamotrigine.
Qiuning Wang, Limei Zhao, Min Liang, Yang Dong, Wenting Yun, Feng Qiu, Homgmei Meng, Yingjie Guo. Ther Drug Monit 2016
16
50

UDP-glucuronosyltransferase (UGT) 2B15 pharmacogenetics: UGT2B15 D85Y genotype and gender are major determinants of oxazepam glucuronidation by human liver.
Michael H Court, Qin Hao, Soundararajan Krishnaswamy, Tanios Bekaii-Saab, Abdul Al-Rohaimi, Lisa L von Moltke, David J Greenblatt. J Pharmacol Exp Ther 2004
79
50

Effect of CYP3A5*3 on carbamazepine pharmacokinetics in Japanese patients with epilepsy.
Takayuki Seo, Naoyuki Nakada, Nao Ueda, Takashi Hagiwara, Nami Hashimoto, Kazuko Nakagawa, Takateru Ishitsu. Clin Pharmacol Ther 2006
24
50

[Effect of UGTIA6 A541G genetic polymorphism on the metabolism of valproic acid in Han epileptic children from Henan].
Yan Wang, Li Gao, Yan-Ping Liu, Nan-Nan Huang, Shu-Jing Xu, Dong-Ju Ma. Zhongguo Dang Dai Er Ke Za Zhi 2010
11
50

Prediction of the effects of genetic polymorphism on the pharmacokinetics of CYP2C9 substrates from in vitro data.
Makiko Kusama, Kazuya Maeda, Koji Chiba, Akinori Aoyama, Yuichi Sugiyama. Pharm Res 2009
32
50

The controversial association of ABCB1 polymorphisms in refractory epilepsy: an analysis of multiple SNPs in an Irish population.
Amre Shahwan, Kevin Murphy, Colin Doherty, Gianpiero L Cavalleri, Clare Muckian, Pat Dicker, Mary McCarthy, Peter Kinirons, David Goldstein, Norman Delanty. Epilepsy Res 2007
58
50

The impact of age on lamotrigine and oxcarbazepine kinetics: a historical cohort study.
Ilse Wegner, Abraham J Wilhelm, Josemir W Sander, Dick Lindhout. Epilepsy Behav 2013
19
50





CYP2C9 allelic variants: ethnic distribution and functional significance.
Hong-Guang Xie, Harish C Prasad, Richard B Kim, C Michael Stein. Adv Drug Deliv Rev 2002
266
50

Predisposition to epilepsy--does the ABCB1 gene play a role?
Laila Nurmohamed, Facundo Garcia-Bournissen, Russell J Buono, Michael W Shannon, Yaron Finkelstein. Epilepsia 2010
25
50


Polymorphism of the cytochrome P450 (CYP) 2C9 gene in Japanese epileptic patients: genetic analysis of the CYP2C9 locus.
J Imai, I Ieiri, K Mamiya, S Miyahara, H Furuumi, E Nanba, M Yamane, Y Fukumaki, H Ninomiya, N Tashiro,[...]. Pharmacogenetics 2000
119
50

ABC transporters during epilepsy and mechanisms underlying multidrug resistance in refractory epilepsy.
Alberto Lazarowski, Liliana Czornyj, Fabiana Lubienieki, Elena Girardi, Silvia Vazquez, Carlos D'Giano. Epilepsia 2007
139
50

The UGT1A3*2 polymorphism affects atorvastatin lactonization and lipid-lowering effect in healthy volunteers.
Sung Kweon Cho, Eun Sil Oh, Kyungsoo Park, Min Soo Park, Jae Yong Chung. Pharmacogenet Genomics 2012
27
50

Evaluation of the genetic component of variability in CYP3A4 activity: a repeated drug administration method.
V Ozdemir, W Kalow, B K Tang, A D Paterson, S E Walker, L Endrenyi, A D Kashuba. Pharmacogenetics 2000
311
50

Nootropic drugs positively modulate alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-sensitive glutamate receptors in neuronal cultures.
A Copani, A A Genazzani, G Aleppo, G Casabona, P L Canonico, U Scapagnini, F Nicoletti. J Neurochem 1992
78
50




The new antiepileptic drugs: pharmacological and clinical aspects.
G Gatti, I Bonomi, G Jannuzzi, E Perucca. Curr Pharm Des 2000
43
50

Association between ABCB1 C3435T polymorphism and drug-resistant epilepsy in Han Chinese.
Patrick Kwan, Larry Baum, Virginia Wong, Ping Wing Ng, Colin Ht Lui, Ngai Chuen Sin, Andrew C F Hui, Evelyn Yu, Lawrence K S Wong. Epilepsy Behav 2007
75
50

Oxcarbazepine accelerates cortisol elimination via cytochrome P450 3A4 induction.
W Högler, S A Wudy, G Luef, M F Hartmann, M Rauchenzauner. Arch Dis Child 2010
17
50

Structural and functional aspects of P-glycoprotein and its inhibitors.
Shirin Mollazadeh, Amirhossein Sahebkar, Farzin Hadizadeh, Javad Behravan, Sepideh Arabzadeh. Life Sci 2018
57
50

Estimation of polymorphisms in the drug-metabolizing enzyme, cytochrome P450 2C19 gene in six major ethnicities of Pakistan.
Sagheer Ahmed, Saima Gul, Muhammad Akhlaq, Abrar Hussain, Sidrah Tariq Khan, Halimur Rehman, Muhammad Hanif Bangash, Fadwa Al Mughairbi, Muhammad Hamid Hamdard. Bioengineered 2021
1
100

Correlations between UGT2B7∗2 gene polymorphisms and plasma concentrations of carbamazepine and valproic acid in epilepsy patients.
Hui Zhang, Wenfang Zhang, Yuechun Li, Jie Yan, Jinfeng Zhang, Baojun Wang. Brain Dev 2018
6
50


Characterisation and PCR-based detection of a CYP2A6 gene deletion found at a high frequency in a Chinese population.
M Oscarson, R A McLellan, H Gullstén, Q Y Yue, M A Lang, M L Bernal, B Sinues, A Hirvonen, H Raunio, O Pelkonen,[...]. FEBS Lett 1999
181
50

[A case of phenytoin intoxication caused by interaction between phenytoin and capecitabine].
Yoshiharu Taguchi, Shutaro Takashima, Kortaro Tanaka. Brain Nerve 2015
2
50




Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.